Clincosm LogoSign in Get a demo

acute myelogenous leukemia

Showing 1 - 25 of 203
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Venetoclax Tablets Crushed and Dissolved Into a Solution

Not yet recruiting
  • Hematologic Malignancy
  • +18 more
  • 1. Drug: The Venetoclax PK study is collecting bodily fluid samples (ie., whole blood and optional cerebrospinal fluid) of patients prescribed venetoclax as crushed tablets per standard of care.
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Nov 8, 2023

Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous

Recruiting
  • Breast Cancer
  • +4 more
  • Web based survey
  • New Haven, Connecticut
  • +6 more
Aug 8, 2023

Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous

Recruiting
  • Breast Cancer
  • +4 more
  • Web bases survey
  • Canton, Ohio
    Cleveland Clinic Mercy Hospital
Aug 2, 2023

Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Biphenotypic Acute Leukemia Trial in Minneapolis (biological, drug,

Not yet recruiting
  • Acute Myelogenous Leukemia
  • +17 more
  • Peripheral Blood Stem Cell Transplant
  • +7 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Mar 27, 2023

Acute Myelogenous Leukemia, Chronic Myelomonocytic Leukemia Trial in Tianjin (LILRB4 STAR-T cells injection)

Not yet recruiting
  • Acute Myelogenous Leukemia
  • Chronic Myelomonocytic Leukemia
  • LILRB4 STAR-T cells injection
  • Tianjin, Tianjin, China
  • +1 more
Feb 12, 2023

Refractory Leukemia, Relapsed Leukemia, Acute Myelogenous Leukemia Trial in Miami (STING-Dependent Activators (STAVs) Loaded

Not yet recruiting
  • Refractory Leukemia
  • +4 more
  • STING-Dependent Activators (STAVs) Loaded Autologous Leukemic Cells
  • Dendritic Cell Vaccine
  • Miami, Florida
    University of Miami
Jan 23, 2023

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, MDS Trial in Tucson (Bendamustine, Cyclophosphamide)

Recruiting
  • Acute Lymphoblastic Leukemia
  • +12 more
  • Tucson, Arizona
    The University of Arizona Cancer Center
Dec 13, 2022

Myeloproliferative Disorders, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial run by the NHLBI (T-cell replete

Completed
Has Results
  • Myeloproliferative Disorders
  • +4 more
  • T-cell replete PBPC allograft
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 12, 2022

Mucopolysaccharidosis I, Mucopolysaccharidosis VI, Adrenoleukodystrophy Trial in Denver, Valhalla, Salt Lake City (Human

Completed
  • Mucopolysaccharidosis I
  • +15 more
  • Human Placental Derived Stem Cell
  • Denver, Colorado
  • +2 more
Oct 24, 2022

Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Valhalla (Gemtuzumab Ozogamicin)

Active, not recruiting
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • Gemtuzumab Ozogamicin
  • Valhalla, New York
    New York Medical College
Sep 26, 2022

Acute Myelogenous Leukemia, AML Trial in Worldwide (Venetoclax, Cytarabine)

Completed
Has Results
  • Acute Myelogenous Leukemia
  • AML
  • Kansas City, Kansas
  • +8 more
Aug 3, 2022

Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, MDS Trial in Saint Louis (procedure, drug, other)

Recruiting
  • Acute Myelogenous Leukemia
  • +4 more
  • Stem cell transplantation
  • +3 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Aug 23, 2022

Acute Myelogenous Leukemia in Relapse, Acute Myelogenous Leukemia, Relapsed, Adult, Acute Myelogenous Leukemia, Adult Trial in

Terminated
  • Acute Myelogenous Leukemia in Relapse
  • +4 more
  • Tucson, Arizona
  • +12 more
Aug 18, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (drug,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +7 more
  • Duarte, California
  • +26 more
Aug 11, 2022

Leukemia, Acute Myelogenous Leukemia, Acute Myeloid Leukemia Trial in Gainesville (Ciprofloxacin 750 MG, Etoposide,

Terminated
Has Results
  • Leukemia
  • +2 more
  • Ciprofloxacin 750 MG
  • +3 more
  • Gainesville, Florida
    UF Health Shands Cancer Hospital
Jul 5, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Lymphoma Trial in United States (biological, drug, procedure)

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +3 more
  • BPX-501 dose 1
  • +5 more
  • Atlanta, Georgia
  • +7 more
Jul 10, 2022

Acute Myelogenous Leukemia Trial in Rochester (Decitabine)

Completed
Has Results
  • Acute Myelogenous Leukemia
  • Rochester, New York
    University of Rochester
Jul 1, 2022

Acute Myelogenous Leukemia Trial in Australia, Canada, United States (Decitabine, Vorinostat, Filgrastim (G-CSF))

Completed
  • Acute Myelogenous Leukemia
  • Los Angeles, California
  • +32 more
Jun 22, 2022

Related Donors Donating PBSC to a Family Member, Healthy Donors, Acute Myelogenous Leukemia Trial in United States (MGTA-145,

Terminated
  • Related Donors Donating PBSC to a Family Member
  • +4 more
  • MGTA-145
  • Plerixafor
  • Duarte, California
  • +7 more
Apr 13, 2022

Acute Myelogenous Leukemia Trial in Atlanta, Boston, Madison (DC/AML Fusion Vaccine, Observation)

Recruiting
  • Acute Myelogenous Leukemia
  • DC/AML Fusion Vaccine
  • Observation
  • Atlanta, Georgia
  • +4 more
Apr 14, 2022

Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Germany, United States (Emavusertib, Azacitidine, Venetoclax)

Active, not recruiting
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • Tampa, Florida
  • +8 more
Apr 5, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in New Hyde Park (radiation, drug,

Completed
  • Acute Lymphoblastic Leukemia
  • +5 more
  • Radiation
  • +3 more
  • New Hyde Park, New York
    Cohen Children's Medical Center
Apr 6, 2022

Acute Myelogenous Leukemia, Multiple Myeloma, MDS Trial in Greece, Spain, United States (This is a non-interventional study)

Completed
  • Acute Myelogenous Leukemia
  • +6 more
  • This is a non-interventional study
  • Bakersfield, California
  • +19 more
Apr 4, 2022

Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Atlanta (Fludarabine, Melphalan,

Completed
  • Chronic Myelogenous Leukemia
  • +9 more
  • Atlanta, Georgia
    Northside Hospital
Apr 4, 2022

High-risk MDS, Acute Myelogenous Leukemia, Systemic Mastocytosis Trial in Minneapolis, Madison (GTB-3550 TriKE® Phase I,

Terminated
  • High-risk Myelodysplastic Syndromes
  • +3 more
  • GTB-3550 TriKE® Phase I
  • GTB-3550 TriKE® Phase II
  • Minneapolis, Minnesota
  • +1 more
Mar 21, 2022